These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 9493289)
41. Abnormal IgG galactosylation and arthritis in MRL-Fas(lpr) or MRL-FasL(gld) mice are under the control of the MRL genetic background. Kuroda Y; Nakata M; Nose M; Kojima N; Mizuochi T FEBS Lett; 2001 Oct; 507(2):210-4. PubMed ID: 11684100 [TBL] [Abstract][Full Text] [Related]
42. Fas ligand (gld)- and Fas (lpr)-deficient mice do not show alterations in the extravasation or apoptosis of inflammatory neutrophils. Fecho K; Cohen PL J Leukoc Biol; 1998 Sep; 64(3):373-83. PubMed ID: 9738665 [TBL] [Abstract][Full Text] [Related]
43. Fas ligand mRNA expression in the mouse central nervous system. Shin DH; Lee E; Kim HJ; Kim S; Cho SS; Chang KY; Lee WJ J Neuroimmunol; 2002 Feb; 123(1-2):50-7. PubMed ID: 11880149 [TBL] [Abstract][Full Text] [Related]
44. Fas and Fas ligand expression in fetal and adult human testis with normal or deranged spermatogenesis. Francavilla S; D'Abrizio P; Rucci N; Silvano G; Properzi G; Straface E; Cordeschi G; Necozione S; Gnessi L; Arizzi M; Ulisse S J Clin Endocrinol Metab; 2000 Aug; 85(8):2692-700. PubMed ID: 10946867 [TBL] [Abstract][Full Text] [Related]
45. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Takahashi T; Tanaka M; Brannan CI; Jenkins NA; Copeland NG; Suda T; Nagata S Cell; 1994 Mar; 76(6):969-76. PubMed ID: 7511063 [TBL] [Abstract][Full Text] [Related]
46. Fulminant hepatitis by Fas-ligand expression in MRL-lpr/lpr mice grafted with Fas-positive livers and wild-type mice with Fas-mutant livers. Li XK; Fujino M; Sugioka A; Morita M; Okuyama T; Guo L; Funeshima N; Kimura H; Enosawa S; Amemiya H; Suzuki S Transplantation; 2001 Feb; 71(4):503-8. PubMed ID: 11258428 [TBL] [Abstract][Full Text] [Related]
47. Renal tubular epithelial cell apoptosis by Fas-FasL-dependent self-injury can augment renal allograft injury. Du C; Guan Q; Yin Z; Masterson M; Zhong R; Jevnikar AM Transplant Proc; 2003 Nov; 35(7):2481-2. PubMed ID: 14611992 [TBL] [Abstract][Full Text] [Related]
48. Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover. French LE; Hahne M; Viard I; Radlgruber G; Zanone R; Becker K; Müller C; Tschopp J J Cell Biol; 1996 Apr; 133(2):335-43. PubMed ID: 8609166 [TBL] [Abstract][Full Text] [Related]
49. Modification of tumor cells with Fas (CD95) antigen gene and Fas ligand (CD95L) gene transfection by electroporation for immunotherapy of cancer. Shimizu M; Yoshimoto T; Matsuzawa A; Takeda Y Mol Biotechnol; 2003 Sep; 25(1):79-87. PubMed ID: 13679638 [TBL] [Abstract][Full Text] [Related]
50. Does Fas ligand or endotoxin contribute to thymic apoptosis during polymicrobial sepsis? Ayala A; Xu YX; Chung CS; Chaudry IH Shock; 1999 Mar; 11(3):211-7. PubMed ID: 10188775 [TBL] [Abstract][Full Text] [Related]
51. [Cell apoptosis and the change of Fas/FasL gene in experimental pulmonary fibrosis]. Li JZ; Li YJ; Li ZH; Kang J; Hou XM; Yu RJ Zhonghua Jie He He Hu Xi Za Zhi; 2005 Mar; 28(3):184-7. PubMed ID: 15854415 [TBL] [Abstract][Full Text] [Related]
52. Apoptosis with FasL+ cell infiltration in the periphery and thymus of corrected autoimmune mice. Kobata T; Takasaki K; Asahara H; Hong NM; Masuko-Hongo K; Kato T; Hirose S; Shirai T; Kayagaki N; Yagita H; Okumura K; Nishioka K Immunology; 1997 Oct; 92(2):206-13. PubMed ID: 9415028 [TBL] [Abstract][Full Text] [Related]
53. Tumor-derived Fas ligand induces toxicity in lymphoid organs and plays an important role in successful chemotherapy. Nagarkatti N Cancer Immunol Immunother; 2000 Apr; 49(1):46-55. PubMed ID: 10782865 [TBL] [Abstract][Full Text] [Related]
54. Expression of Fas-Fas ligand in murine testis. Xu JP; Li X; Mori E; Guo MW; Matsuda I; Takaichi H; Amano T; Mori T Am J Reprod Immunol; 1999 Dec; 42(6):381-8. PubMed ID: 10622469 [TBL] [Abstract][Full Text] [Related]
55. Involvement of the Fas (CD95) system in peripheral cell death and lymphoid organ development. Laouar Y; Sarukhan A; Pasqualetto V; Garcia C; Ezine S Eur J Immunol; 1998 Mar; 28(3):1078-88. PubMed ID: 9541604 [TBL] [Abstract][Full Text] [Related]
56. A role for the Fas/Fas ligand apoptotic pathway in regulating myeloid progenitor cell kinetics. Alenzi FQ; Marley SB; Lewis JL; Chandrashekran A; Warrens AN; Goldman JM; Gordon MY Exp Hematol; 2002 Dec; 30(12):1428-35. PubMed ID: 12482505 [TBL] [Abstract][Full Text] [Related]
57. Expression of Fas-Fas ligand system associated with atresia in murine ovary. Xu JP; Li X; Mori E; Sato E; Saito S; Guo MW; Mori T Zygote; 1997 Nov; 5(4):321-7. PubMed ID: 9563680 [TBL] [Abstract][Full Text] [Related]
58. Fas ligand-induced apoptosis as a mechanism of immune privilege. Griffith TS; Brunner T; Fletcher SM; Green DR; Ferguson TA Science; 1995 Nov; 270(5239):1189-92. PubMed ID: 7502042 [TBL] [Abstract][Full Text] [Related]
59. Oxidized LDL activates fas-mediated endothelial cell apoptosis. Sata M; Walsh K J Clin Invest; 1998 Nov; 102(9):1682-9. PubMed ID: 9802882 [TBL] [Abstract][Full Text] [Related]
60. Fas ligand and Fas receptor are coexpressed in normal human esophageal epithelium: a potential mechanism of apoptotic epithelial turnover. Bennett MW; O'Connell J; O'Sullivan GC; Roche D; Brady C; Collins JK; Shanahan F Dis Esophagus; 1999; 12(2):90-8. PubMed ID: 10466040 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]